Triple

T16185382
Position Surface form Disambiguated ID Type / Status
Subject Office of Surveillance and Epidemiology E392786 entity
Predicate usesDataSource P11520 FINISHED
Object FDA Adverse Event Reporting System
The FDA Adverse Event Reporting System is a U.S. Food and Drug Administration database that collects and analyzes reports of adverse events and medication errors associated with drugs and therapeutic biologic products.
E1199973 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA Adverse Event Reporting System | Statement: [Office of Surveillance and Epidemiology, usesDataSource, FDA Adverse Event Reporting System]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: FDA Adverse Event Reporting System
Context triple: [Office of Surveillance and Epidemiology, usesDataSource, FDA Adverse Event Reporting System]
  • A. Vaccine Adverse Event Reporting System
    The Vaccine Adverse Event Reporting System (VAERS) is a U.S. national surveillance program that collects and analyzes reports of possible side effects following vaccination to monitor vaccine safety.
  • B. FDA Risk Evaluation and Mitigation Strategies authority
    The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
  • C. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: FDA Adverse Event Reporting System
Triple: [Office of Surveillance and Epidemiology, usesDataSource, FDA Adverse Event Reporting System]
Generated description
The FDA Adverse Event Reporting System is a U.S. Food and Drug Administration database that collects and analyzes reports of adverse events and medication errors associated with drugs and therapeutic biologic products.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: FDA Adverse Event Reporting System
Target entity description: The FDA Adverse Event Reporting System is a U.S. Food and Drug Administration database that collects and analyzes reports of adverse events and medication errors associated with drugs and therapeutic biologic products.
  • A. Vaccine Adverse Event Reporting System
    The Vaccine Adverse Event Reporting System (VAERS) is a U.S. national surveillance program that collects and analyzes reports of possible side effects following vaccination to monitor vaccine safety.
  • B. FDA Risk Evaluation and Mitigation Strategies authority
    The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
  • C. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d87f1e49ac8190a311b54d32990576 completed April 10, 2026, 4:39 a.m.
NER Named-entity recognition batch_69e22060dcf88190b7c662946a5f0191 completed April 17, 2026, 11:58 a.m.
NED1 Entity disambiguation (via context triple) batch_69ffff0550b48190ac84946b7254552b completed May 10, 2026, 3:44 a.m.
NEDg Description generation batch_6a0000a8a74c8190925c4140cf4a8520 completed May 10, 2026, 3:51 a.m.
NED2 Entity disambiguation (via description) batch_6a0004ceda8c8190a358f58f76116a7f completed May 10, 2026, 4:08 a.m.
Created at: April 10, 2026, 5:02 a.m.